To report the clinical presentation (systemic and ocular) of hydroa vacciniforme in a Black South African child.
Methods:
Case report.
Results:
A 14-year-old Black boy was seen at the corneal service with cutaneous erosions, varioliform scarring, corneal scarring, cicatricial conjunctivitis and central crystalline corneal opacity.
Conclusion:
We report the first case in the literature of ocular hydroa vacciniforme in a young Black South Africa boy.
GuptaGManIKemmettD.Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol2000; 42(2Pt 1): 208–213.
2.
ParkH-YParkJ-HLeeK-T, et al. A case of hydroa vacciniforme. Ann Dermatol2010; 22(3): 312–315.
3.
OkumusSCoskunEComezG, et al. An unusual case of hydroa vacciniforme with ocular involvement. Med Arch2012; 66(3): 211–212.
4.
StokesWH.Ocular manifestations in hydroa vacciniforme. Arch Ophthalmol1940; 23: 1131–1145.
5.
GoldgeierMHNordlundJJLuckyAW, et al. Hydroa vacciniforme: diagnosis and therapy. Arch Dermatol1982; 118(8): 588–591.
6.
MortazaviHHejaziPAghazadehN, et al. Hydroa vacciniforme with eye involvement: report of two cases. Pediatr Dermatol2015; 32(1): e39–e41.
7.
NitiyaromRWongpraparutC.Hydroa vacciniforme and solar urticaria. Dermatol Clin2014; 32(3): 345–353, viii.
8.
BickersDRDemarLKDeLeoV, et al. Hydroa vacciniforme. Arch Dermatol1978; 114: 1193–1196.
9.
JakobiecFAStacyRCMendozaPR, et al. Hyperplastic corneal pannus: an immunohistochemical analysis and review. Surv Ophthalmol2014; 59(4): 448–453.
10.
DurbecFReguiaïZLéonardF, et al. Efficacy of ω-3 polyunsaturated fatty acids for the treatment of refractory hydroa vacciniforme. Pediatr Dermatol2012; 29: 118–119.
